Low-normal or excessive body mass index: Newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention

被引:120
作者
Ellis, SG
Elliott, J
Horrigan, M
Raymond, RE
Howell, G
机构
[1] Cleveland Clinic Foundation, Cleveland, OH
[2] Cleveland Clinic Foundation, Cleveland, OH 44195, 9500 Euclid Ave.
关键词
D O I
10.1016/S0002-9149(96)00386-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recognized risk factors account for only a small portion of the variance in the 4% to 10% incidence of major ischemic events associated with percutaneous coronary intervention. Body mass index (BMI) (body weight in kg/[height in m](2)) is a clinically useful estimate of body fat and has been shown to correlate with mortality from several causes, We sought to evaluate the effect of BMI as a potential risk factor for the complications of percutaneous coronary intervention in 3,571 consecutive percutaneous coronary intervention patients treated at a single referral center. Patients were prospectively divided into the nonobese (BMI less than or equal to 25), mildly obese (BMI 26-35), and very obese (BMI >35), based on accepted definitions. Multiple logistic regression analyses were used to determine the correlates of major complications from 25 candidate variables, including BMI less than or equal to 25 (n = 614 patients) and BMI >35 (n = 275 patients), recorded prospectively in a relational database. Death occurred in 2.8% of the BMI less than or equal to 25 group, in 3.7% of the BMI >35 group, and in 0.9% of the BMI 26-34 group (p <0.001), but there was no difference in the incidence of other ischemic events. Blood product transfusion was required in 12% of the BMI less than or equal to 25 group, in 7% of the BMI 25-34 group, and in 8% of the BMI >35% group (p = 0.003). Multivariate analysis, after adjustment for other significant correlates, demonstrated that both BMI less than or equal to 25 (odds ratio [OR] = 2.7, p = 0.005) and BMI >35 (OR = 7.4, p <0.001) were independent correlates of death. Low-normal or high BMI is a newly described and powerful risk factor for in-hospital death after percutaneous coronary intervention.
引用
收藏
页码:642 / 646
页数:5
相关论文
共 17 条
[1]   OBESITY AND CARDIAC-FUNCTION [J].
DEDIVITIIS, O ;
FAZIO, S ;
PETITTO, M ;
MADDALENA, G ;
CONTALDO, F ;
MANCINI, M .
CIRCULATION, 1981, 64 (03) :477-482
[2]   ENERGY REQUIREMENT FOR DEFIBRILLATION OF A MARKEDLY OVERWEIGHT PATIENT [J].
DESILVA, RA ;
LOWN, B .
CIRCULATION, 1978, 57 (04) :827-830
[3]   INCIDENCE AND CONSEQUENCES OF PERIPROCEDURAL OCCLUSION - THE 1985-1986 NATIONAL HEART, LUNG, AND BLOOD INSTITUTE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY REGISTRY [J].
DETRE, KM ;
HOLMES, DR ;
HOLUBKOV, R ;
COWLEY, MJ ;
BOURASSA, MG ;
FAXON, DP ;
DORROS, GR ;
BENTIVOGLIO, LG ;
KENT, KM ;
MYLER, RK .
CIRCULATION, 1990, 82 (03) :739-750
[4]   Analysis and comparison of operator-specific outcomes in interventional cardiology - From a multicenter database of 4860 quality-controlled procedures [J].
Ellis, SG ;
Omoigui, N ;
Bittl, JA ;
Lincoff, M ;
Wolfe, MW ;
Howell, G ;
Topol, EJ .
CIRCULATION, 1996, 93 (03) :431-439
[5]   CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION [J].
ELLIS, SG ;
VANDORMAEL, MG ;
COWLEY, MJ ;
DISCIASCIO, G ;
DELIGONUL, U ;
TOPOL, EJ ;
BULLE, TM .
CIRCULATION, 1990, 82 (04) :1193-1202
[6]   CAUSES AND CORRELATES OF DEATH AFTER UNSUPPORTED CORONARY ANGIOPLASTY - IMPLICATIONS FOR USE OF ANGIOPLASTY AND ADVANCED SUPPORT TECHNIQUES IN HIGH-RISK SETTINGS [J].
ELLIS, SG ;
MYLER, RK ;
KING, SB ;
DOUGLAS, JS ;
TOPOL, EJ ;
SHAW, RE ;
STERTZER, SH ;
ROUBIN, GS ;
MURPHY, MC .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (15) :1447-1451
[7]   COMPARISON OF COMPLICATIONS DURING PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY FROM 1977 TO 1981 AND FROM 1985 TO 1986 - THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY REGISTRY [J].
HOLMES, DR ;
HOLUBKOV, R ;
VLIETSTRA, RE ;
KELSEY, SF ;
REEDER, GS ;
DORROS, G ;
WILLIAMS, DO ;
COWLEY, MJ ;
FAXON, DP ;
KENT, KM ;
BENTIVOGLIO, LG ;
DETRE, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (05) :1149-1155
[8]   INCREASED PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND ATHEROTHROMBOSIS [J].
JUHANVAGUE, I ;
ALESSI, MC ;
VAGUE, P .
DIABETOLOGIA, 1991, 34 (07) :457-462
[9]   ABRUPT VESSEL CLOSURE COMPLICATING CORONARY ANGIOPLASTY - CLINICAL, ANGIOGRAPHIC AND THERAPEUTIC PROFILE [J].
LINCOFE, AM ;
POPMA, JJ ;
ELLIS, SG ;
HACKER, JA ;
TOPOL, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) :926-935
[10]   BODY-WEIGHT AND LONGEVITY - A REASSESSMENT [J].
MANSON, JE ;
STAMPFER, MJ ;
HENNEKENS, CH ;
WILLETT, WC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (03) :353-358